ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1204

Validity and reliability of a new ultrasound-based semiquantitative echogenicity grading scale for myositis.

Takeshi Yoshida1, Didem Saygin2 and Jemima Albayda3, 1Johns Hopkins Hospital, Baltimore, MD, 2Rush University Medical Center, Chicago, IL, 3Johns Hopkins University, Baltimore, MD

Meeting: ACR Convergence 2025

Keywords: Imaging, Muscle Biology, Myositis, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1191–1220) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: The Heckmatt grading scale has been widely used as a semiquantitative assessment method for grading muscle echo intensity (EI) on ultrasound; however, this was originally developed for muscular dystrophies in the 1980s. Concerns have been raised regarding poor agreement among assessors and inadequate capture of changes seen with acute myositis. In this study, we test the reliability and construct validity of a new 4-point, semiquantitative grading scale developed for myositis, which defines increases in muscle EI relative to surrounding structures and incorporates changes in muscle architecture that occur with inflammation and damage.

Methods: Ultrasound images of deltoid, biceps brachii, and rectus femoris muscles of myositis patients and controls, obtained from 2015 to 2018 were included in this study. Two experienced raters and one less experienced rater, who had received a two-hour lecture and one training session before the assessment, independently assessed the images. We defined the Hopkins myositis grading scale as follows;Grade 1: Normal – muscle EI equal to or lower than the overlying fat, with clear contrast to perimysial septation and fasciaGrade 2: Mildly Abnormal – muscle EI is slightly increased, may be higher than that of overlying fat layer but lower than that of fascia, but perimysial septations remain well-definedGrade 3: Moderately Abnormal – muscle EI is high but is still less echogenic than fascia, with loss or blurring of contrast to perimysial septationGrade 4: Severely Abnormal – muscle EI is very high, equal to or nearly equal to fascia, potentially accompanied by acoustic shadowsConstruct validity was evaluated using Spearman’s correlation between each grading system and muscle strength, as well as quantitative muscle EI. Interrater and intrarater reliability were evaluated using Cohen’s kappa. Cohen’s kappa was interpreted as substantial for 0.60-0.80 and almost perfect for 0.80-1.00.

Results: A total of 349 images from 61 myositis patients (26 inclusion body myositis (IBM) and 35 non-IBM myositis), and 222 images from 37 healthy controls were included. The Hopkins myositis grading scale demonstrated good correlations with both muscle strength and EI, ranging between rho 0.55 – 0.62, better than the Heckmatt scale (Table). In myositis patients, interrater reliability of the Hopkins myositis grading scale demonstrated substantial agreement (Cohen’s kappa 0.62 – 0.65) while the Heckmatt scale had fair agreement (Cohen’s kappa 0.28 – 0.36). Similarly, intrarater reliability of the Hopkins myositis grading scale was almost perfect and better than the Heckmatt scale (0.78-0.85 vs 0.67).

Conclusion: In myositis patients, the Hopkins myositis grading scale which incorporates more specific parameters to aid in assessing changes in muscle EI and architecture, showed excellent validity and reliability and showed improvements over the original Heckmatt scale. Notably, the less experienced rater demonstrated interrater reliabilities comparable to those of the experienced raters, suggesting that appropriate training can be sufficient for accurate assessment.

Supporting image 1Figure 1. The Hopkins myositis grading scale in healthy controls (A-C) and myositis patients (D-F: immune mediated necrotizing myopathy, G-I: Anti-synthetase syndrome, J-L: inclusion body myositis). A, D, G, J: deltoid. B, E, H, K: biceps brachii. C, F, I, L: rectus femoris. Abbreviation: Hp: the Hopkins myositis grading scale, He: the Heckmatt grading scale.

Supporting image 2Table 1. Validity and reliability of the Hopkins myositis grading scale and the Heckmatt grading scale.


Disclosures: T. Yoshida: None; D. Saygin: None; J. Albayda: None.

To cite this abstract in AMA style:

Yoshida T, Saygin D, Albayda J. Validity and reliability of a new ultrasound-based semiquantitative echogenicity grading scale for myositis. [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/validity-and-reliability-of-a-new-ultrasound-based-semiquantitative-echogenicity-grading-scale-for-myositis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/validity-and-reliability-of-a-new-ultrasound-based-semiquantitative-echogenicity-grading-scale-for-myositis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology